Trial Profile
Clinical trial of IDX 719 + IDX 184 in patients with hepatitis C
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 01 May 2013
Price :
$35
*
At a glance
- Drugs IDX 184 (Primary) ; Samatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 23 Apr 2012 New trial record